Botulinum neurotoxin types A and E require the SNARE motif in SNAP‐25 for proteolysis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  FEBS Letters

• Publication date

  1997-11-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-5793(97)01328-8PMID 9414082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidebook to protein toxins and their use in cell biology

  1997cited by this paper
• The interaction of synaptic vesicle‐associated membrane protein/synaptobrevin with botulinum neurotoxins D and F

  1997cited by this paper
• Neurotransmitter release - four years of SNARE complexes.

  1997cited by this paper
• Substrate residues N‐terminal to the cleavage site of botulinum type B neurotoxin play a role in determining the specificity of its endopeptidase activity

  1996cited by this paper
• Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.

  1996cited by this paper
• Identification of a Novel Syntaxin- and Synaptobrevin/VAMP-binding Protein, SNAP-23, Expressed in Non-neuronal Tissues*

  1996cited by this paper
• Common and distinct fusion proteins in axonal growth and transmitter release

  1996cited by this paper
• Clostridial Neurotoxins and Substrate Proteolysis in Intact Neurons

  1996cited by this paper
• Protein Sorting by Transport Vesicles

  1996cited by this paper
• Structural Determinants of the Specificity for Synaptic Vesicle-associated Membrane Protein/Synaptobrevin of Tetanus and Botulinum Type B and G Neurotoxins*

  1996cited by this paper
• Botulinum neurotoxins: mechanism of action and therapeutic applications.

  1996cited by this paper
• Regulation of Neurite Outgrowth and SNAP-25 Gene Expression by the Brn-3a Transcription Factor (*)

  1995cited by this paper
• Structure and function of tetanus and botulinum neurotoxins

  1995cited by this paper
• Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development.

  1995cited by this paper
• Therapy with botulinum toxin

  1994cited by this paper
• SNARE motif and neurotoxins

  1994cited by this paper
• Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.

  1994cited by this paper
• Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.

  1994cited by this paper
• Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.

  1994cited by this paper
• Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.

  1994cited by this paper
• Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.

  1994cited by this paper
• Multiple loci for synapse protein SNAP-25 in the tetraploid goldfish.

  1993cited by this paper
• Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin.

  1993cited by this paper
• Botulinum neurotoxins serotypes A and E cleave SNAP‐25 at distinct COOH‐terminal peptide bonds

  1993cited by this paper
• Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo

  1993cited by this paper
• Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

  1993cited by this paper
• Evolutionary conservation of synaptosome-associated protein 25 kDa (SNAP-25) shown by Drosophila and Torpedo cDNA clones.

  1993cited by this paper
• Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin.

  1993cited by this paper
• Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

  1992cited by this paper
• Surface topography of histidine residues of tetanus toxin probed by immobilized-metal-ion affinity chromatography.

  1992cited by this paper
• The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations

  1989cited by this paper
• Tetanus and botulinum toxins block the release of acetylcholine from slices of rat striatum and from the isolated electric organ of Torpedo at different concentrations.

  1988cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1987cited by this paper
• Molecular pharmacology of botulinum toxin and tetanus toxin.

  1986cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper

• Bacterial zinc metalloproteases as facilitators of pathogenic success: a review

  2026cites this paper
• Advances in the labelling and selective manipulation of synapses

  2024cites this paper
• Endopeptidase activities of Clostridium botulinum toxins in the development of this bacterium.

  2024cites this paper
• Bacterial AB toxins and host-microbe interactions.

  2022cites this paper
• Ability of human SNAP-23 to generate high molecular weight SDS-resistant ternary SNARE complexes is influenced by C-terminal coil content

  2021cites this paper
• Clostridial Neurotoxins: Structure, Function and Implications to Other Bacterial Toxins

  2021cites this paper
• Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics

  2021cites this paper
• BAcTrace, a tool for retrograde tracing of neuronal circuits in Drosophila

  2020influential citation
• BAcTrace a new tool for retrograde tracing of neuronal circuits

  2020cites this paper
• Evolutionary Features in the Structure and Function of Bacterial Toxins

  2019cites this paper
• Roles of SNAP-25 isoforms in activity-dependent long-term synaptic plasticity

  2019cites this paper
• Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

  2018cites this paper
• Control of neurotransmission by diffusional properties of a presynaptic plasma membrane protein - syntaxin1A

  2018cites this paper
• A Presynaptic Group III mGluR Recruits Gβγ/SNARE Interactions to Inhibit Synaptic Transmission by Cone Photoreceptors in the Vertebrate Retina

  2017cites this paper
• Effects of transgenic expression of botulinum toxins in Drosophila

  2016influential citation
• Inhibitory Effects of Botulinum Toxin Type A on Pyloric Cholinergic Muscle Contractility of Rat.

  2016cites this paper
• Protein Toxins in Modeling Biochemistry

  2016influential citation
• Relevance of Intrinsic Disorder in Protein Structure and Function

  2016cites this paper
• Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.

  2015cites this paper
• ANALYSIS OF PROTEASE ACTIVITY USING MEMBRANE- COATED BIOMIMETIC MICROSPHERES

  2015cites this paper
• Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions.

  2015cites this paper
• Uptake and transport of clostridial neurotoxins

  2015cites this paper
• The Inhibitory Effect of Botulinum Toxin Type A on Rat Pyloric Smooth Muscle Contractile Response to Substance P In Vitro

  2015cites this paper
• Resolution of sub-nanosecond motions in botulinum neurotoxin endopeptidase: An evidence of internal flexibility.

  2015cites this paper
• Fusion of Golgi‐derived vesicles mediated by SNAP‐25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro

  2014cites this paper
• A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A.

  2014cites this paper
• DEVELOPMENT AND KINETIC MODELING OF MULTIPLEX MICROSPHERE ASSAYS FOR HIGH-THROUGHPUT DISCOVERY OF PROTEASE ACTIVE SMALL MOLECULE COMPOUNDS

  2014cites this paper
• Presynaptic Protein Interactions that Regulate Synaptic Strength at Crayfish Neuromuscular Junctions.

  2014influential citation
• Phenotypic effect of botulinum toxin A on Caenorhabditis elegans

  2014influential citation
• Molecular Mechanism and Effects of Clostridial Neurotoxins

  2014cites this paper
• High-throughput screening technologies for botulinum neurotoxins.

  2014cites this paper
• Clostridial neurotoxins: mode of substrate recognition and novel therapy development.

  2014cites this paper
• Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.

  2013cites this paper
• Comparison of Fluorigenic Peptide Substrates PL50, SNAPtide, and BoTest A/E for BoNT/A Detection and Quantification

  2013cites this paper
• Role of the SNARE protein SNAP23 on cAMP-stimulated renin release in mouse juxtaglomerular cells.

  2013cites this paper
• Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission.

  2013cites this paper
• Bioluminescence assay for the highly sensitive detection of botulinum neurotoxin A activity.

  2013cites this paper
• Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

  2013cites this paper
• Dysfunction of rat INS-1E pancreatic ß-cells induced by chronic high glucose stimuli

  2012cites this paper
• METAL ION-MEDIATED INACTIVATION AND SMALL MOLECULE INHIBITION OF THE METALLOPROTEASE IN BOTULINUM NEUROTOXIN A

  2012cites this paper
• Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A

  2012cites this paper
• Inhibition in vivo of the activity of botulinum neurotoxin A by small molecules selected by virtual screening.

  2012cites this paper
• Structure and activity of Clostridium botulinum neurotoxin functional fragments

  2012cites this paper
• Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters.

  2011cites this paper
• Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.

  2011cites this paper
• Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity.

  2011cites this paper
• Regions of recognition by blocking antibodies on the light chain of botulinum neurotoxin A: antigenic structure of the entire toxin.

  2011cites this paper
• An update on the mechanism of action of tetanus and botulinum neurotoxins.

  2011cites this paper
• Cholinergic signalling pathways in the superficial layers of the human bladder : comparing health, detrusor overactivity and the effect of Botulinum Toxin Type A

  2011cites this paper
• High-Throughput Multiplex Flow Cytometry Screening for Botulinum Neurotoxin Type A Light Chain Protease Inhibitors

  2010cites this paper
• Clostridial Neurotoxins: Mechanism of SNARE Cleavage and Outlook on Potential Substrate Specificity Reengineering

  2010cites this paper
• Interactions of Quinolinols, Peptides and SNAP-25 with the Protease Domain of Botulinum Neurotoxin A

  2010influential citation
• A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region.

  2010cites this paper
• Expression of the botulinum neurotoxin serotype D binding domain in Brevibacillus brevis and its evaluation as a candidate vaccine antigen in mice

  2009cites this paper
• Chapter 4 – Interactions Between Botulinum Neurotoxins and Synaptic Vesicle Proteins

  2009cites this paper
• Detection and Quantification of Botulinum Neurotoxin Type A by a Novel Rapid In Vitro Fluorimetric Assay

  2009cites this paper
• Proteomics of regulated secretory organelles.

  2009cites this paper
• Studies of Botulinum Neurotoxins Mechanism of Action

  2009cites this paper
• Microsphere based protease assays and high throughput screening of bacterial toxin proteases

  2009cites this paper
• Tandem fluorescent proteins as enhanced FRET-based substrates for botulinum neurotoxin activity.

  2009cites this paper
• Receptor and substrate interactions of clostridial neurotoxins.

  2009cites this paper
• Drug Insight: biological effects of botulinum toxin A in the lower urinary tract

  2008cites this paper
• Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease.

  2008cites this paper
• Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex.

  2008cites this paper
• Substrate Recognition Mechanism of VAMP/Synaptobrevin-cleaving Clostridial Neurotoxins*

  2008cites this paper
• Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins

  2008cites this paper
• Presynaptic neurotoxins with enzymatic activities.

  2008cites this paper
• Substrate Recognition of VAMP-2 by Botulinum Neurotoxin B and Tetanus Neurotoxin*

  2008cites this paper
• High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.

  2008cites this paper
• Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates.

  2008cites this paper
• How do the Botulinum Neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action

  2008cites this paper
• Structure- and Substrate-based Inhibitor Design for Clostridium botulinum Neurotoxin Serotype A*

  2008cites this paper
• SNAP-25 Substrate Peptide (Residues 180–183) Binds to but Bypasses Cleavage by Catalytically Active Clostridium botulinum Neurotoxin E*

  2008cites this paper
• Antimicrobial Peptides: New Recognition Molecules for Detecting Botulinum Toxins

  2007cites this paper
• Glutamate release mechanisms from megakaryocytes.

  2007cites this paper
• Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.

  2007cites this paper
• Mechanism of Substrate Recognition by Botulinum Neurotoxin Serotype A*

  2007cites this paper
• A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.

  2007cites this paper
• Sequencing the Botulinum Neurotoxin Gene and Related Genes in Clostridium botulinum Type E Strains Reveals orfx3 and a Novel Type E Neurotoxin Subtype

  2007cites this paper
• Multiple Pocket Recognition of SNAP25 by Botulinum Neurotoxin Serotype E*

  2007cites this paper
• Passage of botulinum neurotoxin across intestinal barrier

  2007cites this paper
• Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.

  2006cites this paper
• Unique Substrate Recognition by Botulinum Neurotoxins Serotypes A and E*

  2006cites this paper
• Structural Studies on Intact Clostridium botulinum Neurotoxins Complexed with Inhibitors Leading to Drug Design

  2006cites this paper
• Botulinum Toxin: From Molecule to Clinic

  2006cites this paper
• Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1

  2006influential citation
• Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting

  2006influential citation
• CHAPTER 19 – Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions

  2006cites this paper
• Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.

  2006cites this paper
• CHAPTER 20 – Uptake and transport of Clostridium neurotoxins

  2006cites this paper
• Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin.

  2005cites this paper
• Structural analysis of the catalytic domain of tetanus neurotoxin.

  2005cites this paper
• Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.

  2005cites this paper
• Biologically Active Novel Conformational State of Botulinum, the Most Poisonous Poison*

  2005cites this paper
• Botulinum Neurotoxin Types A, B, and E: Fragmentations by Autoproteolysis and Other Mechanisms Including by O-Phenanthroline–Dithiothreitol, and Association of the Dinucleotides NAD+/NADH with the Heavy Chain of the Three Neurotoxins

  2005cites this paper
• Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme.

  2005cites this paper
• Poison as cure: a clinical review of botulinum toxin as an invaluable drug

  2005cites this paper
• Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells.

  2004cites this paper
• Substrate recognition strategy for botulinum neurotoxin serotype A

  2004cites this paper
• SNAP-23 functions in docking/fusion of granules at low Ca2+.

  2004cites this paper